Morphic Holding - Received Notice From Abbvie Biotechnology It Elected To Terminate Collaboration & Option Agreement

June 21 (Reuters) - Abbvie Inc:

June 21 (Reuters) - Abbvie Inc (ABBV.N) :

MORPHIC HOLDING - ON JUNE 16, RECEIVED NOTICE FROM ABBVIE BIOTECHNOLOGY IT ELECTED TO TERMINATE COLLABORATION & OPTION AGREEMENT DATED OCT 16, 2018
MORPHIC HOLDING - ABBVIE EXERCISED ITS RIGHT TO TERMINATE COLLABORATION AGREEMENT FOR CONVENIENCE
MORPHIC HOLDING INC - TERMINATION WILL BE EFFECTIVE AS OF DECEMBER 13, 2022, OR SUCH EARLIER DATE AS AGREED BY PARTIES
MORPHIC HOLDING - EFFECTIVE UPON TERMINATION OF COLLABORATION AGREEMENT, ALL RIGHTS AND LICENSES GRANTED THEREUNDER SHALL IMMEDIATELY TERMINATE

The copyright of this article belongs to the original author/organization.

The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: editorial@longbridge.global